GGrantIndex
Sort

326,823 grants matching clinical trial

HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus

$2,023,601
Hildegund C. J. Ertl · Wistar Institute · U19 · FY2011 · AI

Mitochondrial Protective Interventions, Aging and Healthspan

$2,023,566
Peter S Rabinovitch · University Of Washington · P01 · FY2017 · AG

Pharmacogenetics of Phase II Drug Metabolizing Enzymes

$2,023,207
Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2014 · GM

EXTENDED DURATION SILVER WOUND DRESSING CLINICAL TRIAL

$2,023,098
Milliken & Company · · FY2010 · Department of Defense

An Advanced Vaccine Candidate To Prevent Zika Virus Infection

$2,022,865
Mark K Slifka · Oregon Health & Science University · R01 · FY2019 · AI

A Six-Month, RCT of Probuphine Safety and Efficacy in Opioid Addiction

$2,022,838
Katherine Beebe Devarney · Titan Pharmaceuticals, Inc. · RC2 · FY2010 · DA

Fragments of TrpRS to Treat Neovascular Eye Diseases

$2,022,588
Martin Friedlander · Scripps Research Institute, The · R24 · FY2006 · EY

GENE THERAPY FOR BRAIN TUMORS

$2,022,442
Massachusetts General Hospital · P01 · FY2000 · CA

Transfusion-Associated Brain Improvement (TABI) Trial: Data Coordinating Center

$2,022,408
Abhik Das · Research Triangle Institute · U01 · FY2015 · HL

HIV VACCINE TRIAL CLINICAL UNIT

$2,022,330
Harvard University (Medical School) · U01 · FY2002 · AI

Immunology Core

$2,022,247
Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIC · FY2016 · AI

PLT+ Characterization and IND-Enabling Studies

$2,022,100
Dean Alan Falb · Stellular Bio, Inc. · R44 · FY2020 · HL

Elevated mitochondrial fusion and function in Down syndrome

$2,021,900
Beverly A. Rothermel · Ut Southwestern Medical Center · R01 · FY2019 · HD

Molecular Strategies to Widen the Therapeutic Index of Radiotherapy

$2,021,847
Quynh-Thu X Le · Stanford University · P01 · FY2023 · CA

Justice Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center

$2,021,759
Kevin Knight · Texas Christian University · UG1 · FY2020 · DA

Stellenbosch University Clinical Trial Unit, Cape Town, South Africa

$2,021,622
Mark Fredric Cotton · Stellenbosch University · U01 · FY2011 · AI

Host-Tumor Cell Interactions in Myeloma:

$2,021,516
Dana-Farber Cancer Institute · P01 · FY2005 · CA

Center for Translational Viral Oncology (CTVO)

$2,021,492
Krzysztof Reiss · Lsu Health Sciences Center · P20 · FY2018 · GM

Clinical Epidemiology and Pathogenesis of Asymptomatic HSV

$2,021,461
Anna Wald · Fred Hutchinson Cancer Research Center · P01 · FY2012 · AI

Head and Neck Cancer SPORE at the University of Wisconsin

$2,021,133
Paul M Harari · University Of Wisconsin-Madison · P50 · FY2023 · CA

Integrative analysis and modeling of human immune responses and pathologies

$2,020,923
John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Multimodal MRI in Multiple Sclerosis

$2,020,887
Daniel Reich · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS

THAPCA Trials - Scientific Application

$2,020,850
Frank W Moler · University Of Michigan At Ann Arbor · U01 · FY2014 · HL

New computational tools for understanding and predicting AD via age-associated DNA methylation changes

$2,020,719
Lily Wang · University Of Miami School Of Medicine · RF1 · FY2022 · NS

Host-Tumor Cell Interactions in Myeloma:

$2,020,671
Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2006 · CA